These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [FIBRINOLYSIN, a new agent against thromboembolic disease]. Prod Pharm; 1959 Sep; 14():502. PubMed ID: 13858182 [No Abstract] [Full Text] [Related]
6. Human fibrinolysin in the treatment of acute thromboembolic disease. ANLYAN WG; WOODHALL B; STICKEL D; MAHALEY MS Bull Soc Int Chir; 1962; 21():273-7. PubMed ID: 13861677 [No Abstract] [Full Text] [Related]
7. The treatment of some problem cases of thromboembolic disease with fibrinolysin. HARLOE JP Angiology; 1959 Aug; 10():283-91. PubMed ID: 14399834 [No Abstract] [Full Text] [Related]
8. Fibrinolysin as an agent for treatment of thromboembolic accidents. CLIFFTON EE JAMA; 1961 Jan; 175():302-6. PubMed ID: 13694109 [No Abstract] [Full Text] [Related]
9. Studies of the plasmin-plasminogen system in thromboembolic diseases; its modifications by thrombolysin therapy. TSITOURIS G; SANDBERG H; DELEON AC; LECKS L; BELLET S Am J Cardiol; 1960 May; 5():680-7. PubMed ID: 13839651 [No Abstract] [Full Text] [Related]
10. [Treatment of thrombosis and embolisms with human fibrinolysin]. BALTER I; BARRIO E Dia Med; 1961 Aug; 33():1536-42. PubMed ID: 13686464 [No Abstract] [Full Text] [Related]
11. [Fibrinolytic therapy and anticoagulation prophylaxis in thromboembolic diseases]. MENEGHINI P Minerva Med; 1955 Feb; 46(13):393-402. PubMed ID: 14355901 [No Abstract] [Full Text] [Related]
12. [Plasmin (fibrinolysin) infusions]. ROSOLLECK H Med Welt; 1961 Oct; 41():2114-8. PubMed ID: 14494137 [No Abstract] [Full Text] [Related]
13. Dose response curves with varying doses of fibrinolysin. WILSON WL; NASO F; LIPPMANN E Am J Cardiol; 1960 Aug; 6():503-6. PubMed ID: 13845148 [No Abstract] [Full Text] [Related]
14. Fibrinolytic agents in surgical practice. Their role as an adjunct to surgical treatment of thromboembolic disease in 37 patients. ANLYAN WG; SILVER D; DEATON HL; FORT L; WEBSTER JL JAMA; 1961 Jan; 175():290-2. PubMed ID: 13683649 [No Abstract] [Full Text] [Related]
15. The present status of the clinical evaluation of fibrinolysin. CHAPPLE RV; SINGHER HO Can Med Assoc J; 1959 Aug; 81(4):231-4. PubMed ID: 13809263 [No Abstract] [Full Text] [Related]
16. Experiences with fibrinolysin in peripheral vascular occlusive disease. ANLYAN WG; DEATON HL; SILVER D Am J Cardiol; 1960 Aug; 6():507-12. PubMed ID: 13793739 [No Abstract] [Full Text] [Related]
17. Thrombolytic therapy. SHERRY S South Med J; 1961 Nov; 54():1287-92. PubMed ID: 13911736 [No Abstract] [Full Text] [Related]
18. [Use of fibrinolysin (plasmin) in thromboembolic diseases]. MACIAS CASTRO I Arch Hosp Univ; 1958; 10(6):463-6. PubMed ID: 13628412 [No Abstract] [Full Text] [Related]
19. Plasmin therapy combined with anticoagulants in severe thrombo-embolic conditions. Preliminary report. STORM O; LARSEN V; MOGENSEN B Acta Chir Scand Suppl; 1961; Suppl 283():315-21. PubMed ID: 13917525 [No Abstract] [Full Text] [Related]
20. Clinical observations in thromboembolic disease treated with fibrinolysin. MOSER KM Angiology; 1959 Aug; 10():319-31. PubMed ID: 14424538 [No Abstract] [Full Text] [Related] [Next] [New Search]